Home › NCT07574645

Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry

SPIDER - Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry

Who can join

All ages · All sexes

Inclusion Criteria:

* Type 1 spinal dural arteriovenous fistula, confirmed on imaging
* Surgically or endovascularly treated
* At least 1 available primary outcome

About the study

Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.

Sponsor: Thomas Jefferson University · Participants: 1,000 · Started: Jan 5, 2026

Contact the study team

• Pascal Jabbour, MD · Phone: 215-955-7000

Official record on ClinicalTrials.gov — NCT07574645

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.